Latest revenue
$4.2M
as of 2026-03-31
Latest net income
$-7.1M
as of 2026-03-31
Net margin
-170.4%
as of 2026-03-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Miscellaneous Chemical Products (10 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 6, 2026.
Community sentiment
Where do you think ASPI is heading?
Price · 5Y
Market data
Price feed temporarily unavailable for ASPI.
5-year trend
What this company does
Item 1. Business Overview We are an advanced materials company dedicated to the development of a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. In addition, in January 2026, we acquired Renergen, which is South Africa’s leading onshore natural gas explorer and the first integrated producer of both liquid helium and LNG (as discussed further below). Our proprietary enrichment technologies, the Aerodynamic Separation Process (“ASP technology”) and Quantum Enrichment technology (“QE technology”), are designed to enable the production of isotopes for a range…
AI summary unavailable — showing raw filing excerpt
Generated from ASPI's filing dated 2026-04-10
Key risks
Item 1A. Risk Factors Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors below together with the information contained elsewhere in this Annual Report on Form 10-K, including Part II, Item 8, “Financial Statements and Supplementary Data” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in our other public filings in evaluating our business. Before you decide to invest in our common stock, you should consider carefully the risks described below, together with the other information contained in this Annual Report, including our financial statements and the related notes.…
AI summary unavailable — showing raw filing excerpt
Generated from ASPI's filing dated 2026-04-10
Profitability
Gross margin
14.3%
63.0%Operating margin
-251.2%
60.5%Net margin
-670.2%
14.3%Return on equity
-78.3%
15.7%Return on assets
-32.1%
6.6%Leverage
Debt / equity
1.44×
48.4%Long-term debt / equity
0.98×
39.9%Debt / assets
59.0%
19.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $4.2M | +279.4% | $-7.1M | +15.8% | -170.4% |
Q4 2025 2025-12-31 | $16.7M | +1295.4% | $-63.3M | -586.8% | -380.2% |
Q3 2025 2025-09-30 | $4.9M | +349.5% | $-12.9M | -75.3% | -263.7% |
Q2 2025 2025-06-30 | $1.2M | +17.2% | $-75.2M | -746.2% | -6271.7% |
Q1 2025 2025-03-31 | $1.1M | +31.1% | $-8.5M | -21.5% | -768.1% |
Q4 2024 2024-12-31 | $1.2M | — | $-9.2M | — | -772.4% |
Q3 2024 2024-09-30 | $1.1M | — | $-7.4M | -74.2% | -676.2% |
Q2 2024 2024-06-30 | $1.0M | — | $-8.9M | -107.2% | -868.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Miscellaneous Chemical Products · SIC 2890
Your notes
Keep private notes on ASPI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$8.3M
Net activity
−$8.3M
Distinct insiders
6
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ASPI
Institutional value
$124.6M
Total shares held
28.4M
Distinct holders
97
-75 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.3M | $36.8M | +1.5M (+22.7%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $22.4M | — | New |
| 3 | UBS Group AG | 2.8M | $12.6M | +435.3K (+18.1%) | Added |
| 4 | EXCHANGE TRADED CONCEPTS, LLC | 2.2M | $9.7M | +783.2K (+55.9%) | Added |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 977.2K | $4.3M | — | New |
| 6 | VANGUARD FIDUCIARY TRUST CO | 753.3K | $3.3M | — | New |
| 7 | JANE STREET GROUP, LLC | 684.5K | $3.0M | -902.5K (-56.9%) | Trimmed |
| 8 | WIM INVESTMENT MANAGEMENT Ltd | 601.4K | $2.7M | +0 (+0.0%) | No change |
| 9 | GROUP ONE TRADING LLC | 595.6K | $2.6M | +151.3K (+34.0%) | Added |
| 10 | Sara-Bay Financial | 586.7K | $2.6M | — | New |
| 11 | Chicago Partners Investment Group LLC | 374.1K | $2.1M | — | New |
| 12 | Rathbones Group PLC | 386.6K | $1.7M | -412.6K (-51.6%) | Trimmed |
| 13 | Caprock Group, LLC | 321.0K | $1.4M | -1.3K (-0.4%) | Trimmed |
| 14 | Bank of New York Mellon Corp | 289.0K | $1.3M | +45.0K (+18.5%) | Added |
| 15 | IMC-Chicago, LLC | 268.5K | $1.2M | -26.0K (-8.8%) | Trimmed |
| 16 | JPMORGAN CHASE & CO | 273.5K | $1.2M | +79.0K (+40.6%) | Added |
| 17 | BANK OF MONTREAL /CAN/ | 231.8K | $1.0M | +113.9K (+96.6%) | Added |
| 18 | Swiss National Bank | 210.1K | $928.6K | +0 (+0.0%) | No change |
| 19 | Nuveen, LLC | 207.4K | $916.9K | +24.7K (+13.5%) | Added |
| 20 | SBI Securities Co., Ltd. | 164.6K | $727.7K | +12.5K (+8.2%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ASPI's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.